DSGN vs WFC · $214.0M cap vs P/E 15, $272.05B cap
Design Therapeutics Inc (DSGN) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported DSGN revenue for 2025-09-30 was $0. Net income was -$53.8M. DSGN currently screens at market cap $214.0M.
WFC does not have a complete income-statement cache yet.
DSGN currently screens at market cap $214.0M. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the DSGN and WFC stock pages for the full models.
Not investment advice.